Petr Smirnov (P Smirnov)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Topics

Psychometric Properties

Dna Methylation

Multiple Myeloma

Top Venues

Cancer research

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Wail Ba-Alawi, Sisira Kadambat Nair, Bo Li, Anthony Mammoliti, Petr Smirnov, Arvind Singh Mer, Linda Z Penn, Benjamin Haibe-Kains
Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity. Cancer research 82 (13) (2022)
Nikta Feizi, Sisira Kadambat Nair, Petr Smirnov, Gangesh Beri, Christopher Eeles, Parinaz Nasr Esfahani, Minoru Nakano, Denis Tkachuk, Anthony Mammoliti, Evgeniya Gorobets, Arvind Singh Mer, Eva Lin, Yihong Yu, Scott Martin, Marc Hafner, Benjamin Haibe-Kains
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis. Nucleic acids research (2021)
George Adam, Ladislav Rampášek, Zhaleh Safikhani, Petr Smirnov, Benjamin Haibe-Kains, Anna Goldenberg
Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology 4 (2020)
Joseph Longo, Petr Smirnov, Zhihua Li, Emily Branchard, Jenna E van Leeuwen, Jonathan D Licht, Benjamin Haibe-Kains, David William Andrews, Jonathan J Keats, Trevor J Pugh, Suzanne Trudel, Linda Z Penn
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia 35 (3) (2020)
Arvind S Mer, Wail Ba-Alawi, Petr Smirnov, Yi X Wang, Ben Brew, Janosch Ortmann, Ming Sound Tsao, David W Cescon, Anna Goldenberg, Benjamin Haibe-Kains
Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts. Cancer research 79 (17) (2019)
Venkata Sk Manem, Meghan Lambie, Ian Smith, Petr Smirnov, Victor Kofia, Mark Freeman, Marianne Koritzinsky, Mohamed E Abazeed, Benjamin Haibe-Kains, Scott V Bratman
Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy. Cancer research 79 (24) (2019)
K L Thu, J Silvester, M J Elliott, W Ba-Alawi, M H Duncan, A C Elia, A S Mer, Petr Smirnov, Z Safikhani, B Haibe-Kains, T W Mak, D W Cescon
Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America 115 (7) (2018)
Zhaleh Safikhani, Petr Smirnov, Kelsie L Thu, Jennifer Silvester, Nehme El-Hachem, Rene Quevedo, Mathieu Lupien, Tak W Mak, David Cescon, Benjamin Haibe-Kains
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro. Nature communications 9 (1) (2018)
Zhaleh Safikhani, Petr Smirnov, Kelsie L Thu, Jennifer Silvester, Nehme El-Hachem, Rene Quevedo, Mathieu Lupien, Tak W Mak, David Cescon, Benjamin Haibe-Kains
Gene isoforms as expression-based biomarkers predictive of drug response in vitro. Nature communications 8 (1) (2017)